These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8533537)

  • 1. Pharmacokinetics and pharmacodynamics of the benzylisoquinolinium muscle relaxants.
    Hull CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():13-7. PubMed ID: 8533537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
    Atherton DP; Hunter JM
    Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of the benzylisoquinolinium relaxants.
    Savarese JJ; Wastila WB
    Acta Anaesthesiol Scand Suppl; 1995; 106():91-3. PubMed ID: 8533554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical and basic pharmacology of mivacurium: a short-acting nondepolarizing benzylisoquinolinium diester neuromuscular blocking drug.
    Savarese JJ; Lien CA; Belmont MR; Rubin L
    Acta Anaesthesiol Scand Suppl; 1995; 106():18-22. PubMed ID: 8533538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 51W89: preliminary data.
    Hunter JM; Eastwood NB; Boyd AH; Parker CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():94. PubMed ID: 8533555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral link model as an alternative for pharmacokinetic-pharmacodynamic modeling of drugs having a very short elimination half-life.
    Laurin J; Donati F; Nekka F; Varin F
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):7-25. PubMed ID: 11253615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mivacurium chloride--a comparative profile.
    Diffenbach C; Buzello W; Mellinghoff H
    Acta Anaesthesiol Scand Suppl; 1995; 106():23-5. PubMed ID: 8533540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on newer neuromuscular blocking drugs.
    Holm H; Ostergaard D
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):108-13. PubMed ID: 7710219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).
    Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Pedersen NA; Skovgaard LT
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1219-25. PubMed ID: 14616318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
    Lien CA; Schmith VD; Embree PB; Belmont MR; Wargin WA; Savarese JJ
    Anesthesiology; 1994 Jun; 80(6):1296-302. PubMed ID: 8010476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of mivacurium blockade by low dose of pancuronium: a pharmacokinetic study.
    Motamed C; Menad R; Farinotti R; Kirov K; Combes X; Bouleau D; Feiss P; Duvaldestin P
    Anesthesiology; 2003 May; 98(5):1057-62. PubMed ID: 12717125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacodynamics and pharmacokinetics of mivacurium in children.
    ØStergaard D; Gätke MR; Berg H; Rasmussen SN; Viby-Mogensen J
    Acta Anaesthesiol Scand; 2002 May; 46(5):512-8. PubMed ID: 12027844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium.
    Ostergaard D; Rasmussen SN; Viby-Mogensen J; Pedersen NA; Boysen R
    Anesthesiology; 2000 Jun; 92(6):1581-7. PubMed ID: 10839906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle relaxants: a clinical update.
    Buzello W; Diefenbach C; Nigrovic V
    Acta Anaesthesiol Scand Suppl; 1996; 109():165-7. PubMed ID: 8901994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium.
    Ali HH; Savarese JJ; Embree PB; Basta SJ; Stout RG; Bottros LH; Weakly JN
    Br J Anaesth; 1988 Nov; 61(5):541-6. PubMed ID: 2905143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancy of recovery times related to potency between atracurium and mivacurium simultaneously administered in isolated forearms.
    Kim SY; Hwang KH; Ok SY; Kim SI; Kim SC; Park W
    Anaesthesia; 1995 Jun; 50(6):507-9. PubMed ID: 7618663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the recovery profile of mivacurium independent of the rate of decay of its plasma concentration in patients with normal plasma cholinesterase activity?
    Nijs N; Duvaldestin P; Slavov V; Dhonneur G
    Acta Anaesthesiol Scand; 1998 Nov; 42(10):1175-9. PubMed ID: 9834800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
    Frampton JE; McTavish D
    Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and steady state pharmacodynamics of mivacurium in children.
    Markakis DA; Lau M; Brown R; Luks AM; Sharma ML; Fisher DM
    Anesthesiology; 1998 Apr; 88(4):978-83. PubMed ID: 9579507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New skeletal muscle relaxants.
    Caldwell JE
    Int Anesthesiol Clin; 1995; 33(1):39-60. PubMed ID: 7635557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.